MetLife Stock Quote MET - Stock Price, News, Charts, Message Board, Trades

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NYSE
MetLife Inc (MET) Quote

MetLife Inc (MET)

71.65

-1.22

(-1.67%)

At close: May 23 4:00PM

Delayed by 15 minutes

71.65

-1.22

( -1.67% )

After Hours: 5:11PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

71.65

Bid

-

Ask

-

Volume

3,410,915

71.395 Day's Range 72.645

49.38 52 Week Range 74.675

Market Cap

Previous Close

72.87

Open

72.56

Last Trade

Last Trade Time

19:00:00

Financial Volume

$ 245,725,796

VWAP

72.041

Average Volume (3m)

3,022,746

Shares Outstanding

723,020,313

Dividend Yield

2.90%

PE Ratio

37.54

Earnings Per Share (EPS)

1.91

Revenue

66.91B

Net Profit

1.38B

MetLife-once a mutual company before the 2000 demutualization-is the largest life insurer in the U.S. by assets and provides a variety of insurance and financial services products. Outside the United States, MetLife operates in Japan and more than 40 countries in Latin America, Asia-Pacific, Europe,... MetLife-once a mutual company before the 2000 demutualization-is the largest life insurer in the U.S. by assets and provides a variety of insurance and financial services products. Outside the United States, MetLife operates in Japan and more than 40 countries in Latin America, Asia-Pacific, Europe, and the Middle East. Show more

Sector

Life Insurance

Industry

Life Insurance

Website

www.metlife.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

MetLife Inc is listed in the Life Insurance sector of the New York Stock Exchange with ticker MET. The last closing price for MetLife was $72.87. Over the last year, MetLife shares have traded in a share price range of $ 49.38 to $ 74.675.

MetLife currently has 723,020,313 shares outstanding. The market capitalization of MetLife is $51.80 billion. MetLife has a price to earnings ratio (PE ratio) of 37.54.

Overall Flow

Bullish

Net Premium

479k

Calls / Puts

500.00%

Buys / Sells

20.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

MetLife Launches My Leave Navigator to Support Employees Navigating Leave

New holistic digital experience to improve employee experience from pre-leave planning to claim submission and beyond MetLife, a leading provider of disability and absence management services...

Form 8-K - Current report

MetLife Declares Second Quarter 2024 Preferred Stock Dividends

MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.43023800 per share on the company’s floating rate non-cumulative...

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

MetLife to Hold Investor Conference

MetLife, Inc. (NYSE: MET) will hold an investor conference in New York City on Thursday, December 12, 2024. Presenters will include members of MetLife's senior management team. Further details...

Valor Games Southeast Celebrates ‘12 Years Strong’

Adapted sports event for Veterans with disabilities hosted by non-profit Bridge II Sports, and supported by presenting sponsor MetLife Bridge II Sports (BIIS) is honored to bring the spirit of...

MetLife Announces New $3 Billion Share Repurchase Authorization

MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is...

MetLife CFO John McCallion Provides First Quarter 2024 Financial Update Video

MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a first...

MetLife Increases Common Stock Dividend by 4.8%

MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a second quarter 2024 common stock dividend of $0.545 per share, an increase of 4.8% from the first quarter...

MetLife Launches My Leave Navigator to Support Employees Navigating Leave

New holistic digital experience to improve employee experience from pre-leave planning to claim submission and beyond MetLife, a leading provider of disability and absence management services...

Form 8-K - Current report

MetLife Declares Second Quarter 2024 Preferred Stock Dividends

MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.43023800 per share on the company’s floating rate non-cumulative...

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

MetLife to Hold Investor Conference

MetLife, Inc. (NYSE: MET) will hold an investor conference in New York City on Thursday, December 12, 2024. Presenters will include members of MetLife's senior management team. Further details...

Valor Games Southeast Celebrates ‘12 Years Strong’

Adapted sports event for Veterans with disabilities hosted by non-profit Bridge II Sports, and supported by presenting sponsor MetLife Bridge II Sports (BIIS) is honored to bring the spirit of...

MetLife CFO John McCallion Provides First Quarter 2024 Financial Update Video

MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and chief financial officer, MetLife, Inc., and head of MetLife Investment Management, has provided a first...

MetLife Increases Common Stock Dividend by 4.8%

MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a second quarter 2024 common stock dividend of $0.545 per share, an increase of 4.8% from the first quarter...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.85	-2.51700680272	73.5	74.45	71.395	2744486	73.20037791	CS
4	-0.77	-1.06324219829	72.42	74.45	68.06	3161868	71.86057928	CS
12	1.9	2.72401433692	69.75	74.675	68.06	3022746	71.7824123	CS
26	8.76	13.929082525	62.89	74.675	62.8147	3476595	69.04096119	CS
52	19.23	36.6844715757	52.42	74.675	49.38	3807806	63.72166001	CS
156	6.74	10.3836080727	64.91	77.36	48.95	4376369	63.98943578	CS
260	24.16	50.8738681828	47.49	77.36	22.85	4960525	54.91728844	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ONMDOneMedNet Corporation	$ 2.26 (53.74%)	14.16M
VSTMVerastem Inc	$ 18.62 (52.87%)	155.63k
CADLCandel Therapeutics Inc	$ 14.95 (39.85%)	535.65k
BIORBiora Therapeutics Inc	$ 0.5882 (18.35%)	179.04k
MRUSMerus NV	$ 51.05 (15.84%)	192.62k
SNSESensei Biotherapeutics Inc	$ 0.7999 (-44.83%)	386.11k
GNLXGenelux Corporation	$ 3.48 (-24.35%)	60.64k
EVOKEvoke Pharma Inc	$ 0.39 (-16.13%)	95.44k
SVMHSRIVARU Holding Ltd	$ 0.17 (-15.63%)	3.5M
NSPRInspireMD Inc New	$ 2.13 (-15.48%)	3.01k
GWAVGreenwave Technology Solutions Inc	$ 0.0897 (1.24%)	94.65M
PEGYPineapple Energy Inc	$ 0.215 (-11.16%)	21.11M
ONMDOneMedNet Corporation	$ 2.26 (53.74%)	14.16M
HLTHCue Health Inc	$ 0.102 (8.17%)	10.49M
ASTIAscent Solar Technologies Inc	$ 0.198 (-7.78%)	8.21M

DewDiligence

DewDiligence 10 months ago

MET 2Q23 CC transcript:

https://finance.yahoo.com/news/q2-2023-metlife-inc-earnings-041804027.html

DewDiligence

DewDiligence 10 months ago

MET 2Q23 results…

PR:
https://finance.yahoo.com/news/metlife-announces-second-quarter-2023-201500351.html

5-minute video:
https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-201500141.html

DewDiligence

DewDiligence 12 months ago

MET inks reinsurance deal—boosts buyback authorization_to $4B…

PR:
https://www.sec.gov/Archives/edgar/data/1099219/000119312523153472/d459413dex991.htm

CC slides:
https://www.sec.gov/Archives/edgar/data/1099219/000119312523153472/d459413dex992.htm

DewDiligence

DewDiligence 1 year ago

Once again, MET had weak results in private equity. I warned about the unsustainable nature of this source of income some time ago in #msg-167739042.

DewDiligence

DewDiligence 1 year ago

MET reports 1Q23 results—$3B buyback authorization—(incremental_to_existing_ $200M_unused_authorization):

https://finance.yahoo.com/news/metlife-announces-first-quarter-2023-201500306.html

https://finance.yahoo.com/news/metlife-announces-3-billion-share-201500413.html

https://finance.yahoo.com/news/1-metlife-profit-drops-lower-202436529.html

CFO’s 5-minute video:
https://www.metlife.com/about-us/newsroom/#video

DewDiligence

DewDiligence 1 year ago

MET increases annualized dividend to $2.08 (from $2.00):

https://finance.yahoo.com/news/metlife-increases-common-stock-dividend-201500854.html

At the current share price ($59.21), the new annualized payout represents a yield of 3.5%.

DewDiligence

DewDiligence 1 year ago

MET 4Q22 CC transcript:

https://finance.yahoo.com/news/metlife-inc-nyse-met-q4-210716721.html

DewDiligence

DewDiligence 1 year ago

MET 5-min video by CFO on 4Q22 results:

https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-211500827.html

DewDiligence

DewDiligence 1 year ago

MET 4Q22 results_hit_by_lower private-equity income:

https://finance.yahoo.com/news/metlife-announces-full-fourth-quarter-211500555.html

I commented on the lack of sustainability of private-equity income such income in a post one year ago (#msg-167739042).

DewDiligence

DewDiligence 1 year ago

Fortunately, MET is no longer in the business of selling retail life insurance in the US:

https://www.wsj.com/articles/stock-selloff-hits-life-insurers-fastest-growing-product-11671815626

pepeoil

pepeoil 1 year ago

Buy this bish and retire. Collect from this little sweet thang

DewDiligence

DewDiligence 2 years ago

MET CFO's 5-minute video on 3Q22 results:

https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-201500184.html

Note: MET is +20% YTD; it is a beneficiary of higher interest rates.

DewDiligence

DewDiligence 2 years ago

MET reports 3Q22 results:

https://www.metlife.com/content/dam/metlifecom/us/homepage/about-us/newsroom/earnings-releases/Q3_2022_Earnings_News_Release.pdf

• Net income of $331 million, or $0.41 per share, compared to net income of $1.5 billion, or $1.77 per share, in the third quarter of 2021.

• Adjusted earnings of $966 million, or $1.21 per share, compared to adjusted earnings of $2.1 billion, or $2.39 per share, in the third quarter of 2021.

• Book value of $27.00 per share, down 65 percent from $77.24 per share at September 30, 2021.

• Book value, excluding accumulated other comprehensive income (AOCI) other than foreign currency translation adjustments (FCTA), of $54.37 per share, down 5 percent from $57.29 per share at September 30, 2021.

• Return on equity (ROE) of 4.9 percent.

• Adjusted ROE, excluding AOCI other than FCTA, of 8.9 percent.

• Holding company cash and liquid assets of $5.2 billion at September 30, 2022, which is above the target cash buffer of $3.0 - $4.0 billion.

DewDiligence

DewDiligence 2 years ago

MET 2Q22 results…

Investment income from private equity was way down from the (unsustainable) level in 2Q21; this was offset to some degree by lower life-insurance claims due to COVID.

PR:
https://finance.yahoo.com/news/metlife-announces-second-quarter-2022-201500041.html

5-minute video:
https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-201500266.html

DewDiligence

DewDiligence 2 years ago

MET analysis—1Q22 non-GAAP EPS was -15% YoY due to weaker (but still objectively strong) results in private-equity investments. In #msg-167739042, I asked rhetorically how long MET could continue to post superlative results from private equity. Now, we’re seeing a regression to the mean (or perhaps worse).

MET’s insurance business benefits from higher interest rates insofar as MET is effectively short fixed income (i.e. it has net liabilities for eventual insurance claims). However, in recent quarters, the gains on MET’s private-equity investments have outweighed the interest-rate effect mentioned above.

All told, I’m not especially bullish on MET; however, I manage a portfolio that has a MET position with a cost basis of zero, stemming from MET’s de-mutualization in 2001.

DewDiligence

DewDiligence 2 years ago

MET—New $3B buyback authorization accompanies 1Q22 results…

Buyback PR:
https://investor.metlife.com/news-and-events/financial-press-releases/news-details/2022/MetLife-Announces-New-3-Billion-Share-Repurchase-Authorization/default.aspx

1Q22 PR:
https://investor.metlife.com/news-and-events/financial-press-releases/news-details/2022/MetLife-Announces-First-Quarter-2022-Results/default.aspx

CFO’s 5-minute video on 1Q22 results:
https://www.metlife.com/about-us/newsroom/#video

Note: The new $3B buyback authorization is in addition to $475M remaining on the previous buyback authorization—i.e. the total authorization is for ~$3.5B.

DewDiligence

DewDiligence 2 years ago

MET increases annualized dividend to $2.00 (from $1.92):

https://finance.yahoo.com/news/metlife-increases-common-stock-dividend-201500238.html

At the current share price ($66.72), the new annualized payout represents a yield of 3.0%.

DewDiligence

DewDiligence 2 years ago

MET CFO’s 5-min video on 4Q21 results:

https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-211500964.html

Take all those superlatives with a grain of salt.

DewDiligence

DewDiligence 2 years ago

MET 4Q21—Poor underwriting again bailed out by private-equity investment gains:

https://finance.yahoo.com/news/insurer-metlifes-quarterly-profit-beats-212327232.html

How long can MET continue to log outsized results in private equity? [Rhetorical]

DewDiligence

DewDiligence 3 years ago

MET 3Q21 results…

PR:
https://finance.yahoo.com/news/metlife-announces-third-quarter-2021-201500644.html

Bloomberg:
https://finance.yahoo.com/news/metlife-beats-estimates-strong-private-205930019.html

CFO’s 5-minute video:
https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-201500359.html

DewDiligence

DewDiligence 3 years ago

MET 2Q21 CC transcript:

https://finance.yahoo.com/m/37c1a2ad-eee1-3b39-9666-37cfd46923c9/metlife-inc-(met)-q2-2021.html

DewDiligence

DewDiligence 3 years ago

MET 2Q21 results—new $3B buybcak authorization:

https://investor.metlife.com/news-and-events/financial-press-releases/news-details/2021/MetLife-Announces-Second-Quarter-2021-Results/default.aspx

https://finance.yahoo.com/news/metlife-announces-3-billion-share-201500416.html

5-min video on 2Q21 results:
https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-201500006.html

DewDiligence

DewDiligence 3 years ago

MET 1Q21 results:

https://investor.metlife.com/files/Q12021/MET_1Q21_Earnings_Release-FINAL.pdf

DewDiligence

DewDiligence 3 years ago

MET increases annualized dividend to $1.92 (from $1.84):

https://finance.yahoo.com/news/metlife-increases-common-stock-dividend-201500216.html

At the current share price ($63.36), the new annualized payout represents a yield of 3.0%.

DewDiligence

DewDiligence 3 years ago

MET 4Q20_results_produce_modest_“relief”_rally:

https://finance.yahoo.com/news/metlife-announces-full-fourth-quarter-211500280.html (PR)

https://finance.yahoo.com/news/metlife-cfo-john-mccallion-provides-211500418.html (5-min CEO video)

https://finance.yahoo.com/news/metlife-profit-rises-marginally-investment-211931389.html (Reuters)

The stock is +3% in AH trading.

DewDiligence

DewDiligence 3 years ago

MET sells P&C business to Zurich Insurance for $3.94B—inline with prior reports—proceeds to be used for share buybacks (under new $3B authorization):

https://finance.yahoo.com/news/metlife-sell-auto-home-business-054600801.html

https://finance.yahoo.com/news/metlife-announces-3-billion-share-054800208.html

DewDiligence

DewDiligence 3 years ago

MET partners with SDC:

https://www.globenewswire.com/news-release/2020/11/23/2131807/0/en/SmileDirectClub-Partners-With-MetLife.html

DewDiligence

DewDiligence 4 years ago

MET near deal to divest property/casualty business for $4B:

https://finance.yahoo.com/news/exclusive-zurich-insurance-nears-4-165136694.html

P&C is a relatively small portion of MET’s business portfolio.

Femto99

Femto99 4 years ago

Interesting. Thx

DewDiligence

DewDiligence 4 years ago

MET 3Q20 results:

https://finance.yahoo.com/news/metlife-announces-third-quarter-2020-211500883.html

The stock is flat in AH trading.

DewDiligence

DewDiligence 4 years ago

MET acquires vision-care insurer—Versant Health—for $1.68B in cash…

PR:
https://finance.yahoo.com/news/metlife-acquire-versant-health-owner-110000235.html

Slides:
https://www.sec.gov/Archives/edgar/data/1099219/000109921920000319/irpresentationverandav18.htm

Versant has 35M members to be folded into MET’s Group benefits segment.

DewDiligence

DewDiligence 4 years ago

MET—(-6%/AH)—reports 2Q20 results—the main negative in the quarter was not COVID-19 claims, but rather losses on private equity and derivative securities:

https://finance.yahoo.com/news/metlife-announces-second-quarter-2020-201500963.html

https://s23.q4cdn.com/579645270/files/doc_financials/2020/q2/MET_2Q20_Supplemental_Slides-FINAL.pdf

https://finance.yahoo.com/news/metlife-quarterly-profit-nosedives-lower-201514460.html MetLife said it had higher COVID-related claims during the quarter, but did not provide specifics. The disease's effects in the third quarter would be largely offset by underwriting margins, the company said.

MetLife reported $710 million in net derivative losses, compared with $724 million in derivative gains a year ago. That’s a $1.43B negative swing, YoY, but I can’t really complain insofar as MET gained $4.2B on derivatives during 1Q20 (#msg-155475813).

DewDiligence

DewDiligence 4 years ago

MET 1Q20 CC transcript:

https://finance.yahoo.com/news/edited-transcript-met-earnings-conference-231028080.html

Femto99

Femto99 4 years ago

Smart move by the company. I had a very small short position to play after seeing someone called on shorting MET. I closed after seeing MET increased their dividend. Some learning experiences for me. Thank you for your postings.

MET is a good company.

DewDiligence

DewDiligence 4 years ago

MET logged a $4.2B gain in 1Q20 from derivatives to hedge interest rates. Wow.

DewDiligence

DewDiligence 4 years ago

MET 1Q20 results:

https://www.sec.gov/Archives/edgar/data/1099219/000109921920000200/ex991earningsreleaseta.htm

Astonishingly, MET says that COVID-19 will have only a “modest” impact on 2020 financial results—see slide #10 at: https://s23.q4cdn.com/579645270/files/doc_financials/2020/Q1/MET_1Q-20-Supplemental-Slides-FINAL.pdf .

DewDiligence

DewDiligence 4 years ago

MET boosts dividend—forward yield=5.2%:

https://finance.yahoo.com/news/metlife-increases-common-stock-dividend-201500280.html MetLife, Inc…today announced that its Board of Directors has declared a second quarter 2020 common stock dividend of $0.46 per share, an increase of 4.5 percent from the first quarter common stock dividend of $0.44 per share. The dividend will be payable on June 12, 2020, to shareholders of record as of May 8, 2020. The new annualized payout is $1.84, which is 5.2% of the current share price ($35.18).

Femto99

Femto99 4 years ago

Thanks a lot for your insights!

DewDiligence

DewDiligence 4 years ago

MET has been unusually volatile lately because investors are finding it hard to get a handle on the effect of the pandemic on MET’s various business segments. The volatility will likely continue until MET announces 1Q19 results and updated 2020 guidance on 5/6/20 (after the market close).

For related info, please see:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154938718 and
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154310158

Femto99

Femto99 4 years ago

MET is coming down pretty hard today. What is the cause? I have been reading the 10k but it is such a big company.

DewDiligence

DewDiligence 4 years ago

Despite the discombobulated corporate-bond market, MET managed to issue $1B of 10-year bonds paying interest @4.55% in a deal that closed today:

https://www.sec.gov/ix?doc=/Archives/edgar/data/1099219/000119312520082648/d898812d8k.htm

This is encouraging and might signal a bottom for the stock, which has dropped an astonishing 55% since 2/12/20.

Please see #msg-154310158 for related info.

DewDiligence

DewDiligence 4 years ago

Please see #msg-154310158. I don't know anything about the deal you mentioned. Regards, Dew

PENNIEStoSTACKS

PENNIEStoSTACKS 4 years ago

DD why did the MET chart drop the way it has and do you know anything about the deal they have with SOLI https://investorshub.advfn.com/boards/replies.aspx?msg=154373738

DewDiligence

DewDiligence 4 years ago

That's not the reason. Life insurance is now a pretty small portion of MET's overall business. See #msg-154239470.

creyno58

creyno58 4 years ago

Because they have to pay when people die!

Femto99

Femto99 4 years ago

DewDiligence

DewDiligence 4 years ago

For MET, lower interest rates lead to lower earnings.

Femto99

Femto99 4 years ago

Why is it going down so fast?

DewDiligence

DewDiligence 4 years ago

MET 4Q19 CC transcript:

https://finance.yahoo.com/news/edited-transcript-met-earnings-conference-123752237.html

DewDiligence

DewDiligence 4 years ago

MET 4Q19 results:

https://investor.metlife.com/news-and-events/financial-press-releases/news-details/2020/MetLife-Announces-Full-Year-and-Fourth-Quarter-2019-Results/default.aspx

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions